Client: Abbott Virology In 2010, US Treatment Guidelines identified lopinavir/ritonavir as the preferred protease inhibitor for the treatment of … MORE
Featured Work
A new direction in the treatment of Peyronie’s disease
Client: Janssen Australia When Janssen was granted a second indication for collagenase clostridium histolyticum by the Therapeutic Goods Administration – for … MORE
Vikings Disease: Disease Awareness Brand
Leo Creative was commissioned to develop a disease awareness brand for Dupuytren's contracture. Dupuytren's contracture is also known as "Vikings Disease", so … MORE
Brand Identity: more than a logo
Client: NEXUS APAC Group Many people mistakenly believe that a brand is just a logo, but that couldn’t be further from the truth. Even if we do just … MORE
Rebranding an industry association
Client: Generic Industry Medicines Association (GMiA) The generic medicines industry is undergoing significant change. The introduction of a new category … MORE
Our approach to branding
There are many brand agencies out there and most approach branding from the foundation of one or two core competencies. There are agencies that have a … MORE
Launching a new treatment for Dupuytren’s contracture
Client: Janssen Australia Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s … MORE
Barker College Prospectus
Client: Barker College When Leo Creative was asked to create a new enrolment prospectus, we knew photography would be critical in communicating school … MORE
Patient and physician demonstration kits
Client: Janssen Australia A common barrier to treatment with some drugs can be administration. This is certainly the case for Janssen’s treatment for … MORE